Magallanes, Leonisa .

HRN: 29-41-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/06/2026
08/08/2026
IVT
500mg
Q8
LTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: